Thank you to the European Cancer Organisation for showcasing our project at the #EuropeanCancerSummit 2025! Special thanks also to @pce-europe.bsky.social for participating at the event 💜 #pancreaticcancer #cancersummit

- descubrimiento de una variante genética que aumenta el riesgo (Francisco X. Real)  - avances hacia una biopsia líquida que permita la detección precoz con un análisis de sangre (Nuria Malats y @hps2022.bsky.social en @pancaid.bsky.social )

Today is #WorldPancreaticCancerDay 💜 #Pancreaticcancer is projected to become the second leading cause of cancer-related deaths in Western societies by 2030. A stark reminder of why our work matters. Today, our thoughts are with all patients and families affected by this devastating disease. 💜 #WPCD

Honored to host the 3rd Annual Cluster Meeting of the Prevention & Early Detection (Screening) Cluster in Brussels. We're joined by our cluster members MammoScreen, DIOPTRA, SANGUINE, LUCIA, and @oncoscreen-project.bsky.social. @horizoneu.bsky.social @ec.europa.eu #CancerPrevention #EarlyDetection

Such a pleasure to lead this consortium together with #klauspantel from #UKE! @ki.se is participating with several departments including #CLINTEC, #LIME, #NVS #yvonnewengström #niklaszethraeus

Writing from #Brussels @ec.europa.eu where we are meeting for our 🇪🇺 project @pancaid.bsky.social #pancreaticcancer is still a medical emergency!

In the afternoon sessions, we discuss work packages 1 – 3, first each progress separately, then jointly in a planum discussion. 1️⃣ Patient cohorts & sample collection 2️⃣ #liquidbiopsy diagnostis 3️⃣ AI analysis & data management #PancSky

We just had our PANCAID ECS session, where each ECS gave an update on their individual research projects. Thank you to Ebba Asplund, Kim-Lea Reese, Robert Wittram, Pabolo Villoslada-Blanco, Sergio Sabroso and Mireia Andueza for your presentations and contributions! #pancreaticcancer #earlydetection

Bonjour and goedendag from Brussels! Our 4th PANCAID General Assembly Meeting just kicked off with a masterclass shared by Klaus Pantel and Catherine Alix-Panabieres, on #Liquidbiopsy diagnostics #pancreaticcancer @cathiepana.bsky.social

Both @nuriamalats.bsky.social & me at @champalimaudf.bsky.social 2nd International meeting on #pancreaticcancer @peterbaileychamp.bsky.social from the #PANCAIM / #PANORAMA @radboudumc.bsky.social and @pancaid.bsky.social @euprojectpulse.bsky.social EU projects! Great discussions w/ our US friends!

How is #AI transforming early cancer detection? Experts from @phireproject.bsky.social, PANCAIM and PANCAID explore how data, innovation & collaboration drive precision oncology. 🎙 Moderated by Federica Zanca (EIC) 📺 Watch now: www.youtube.com/watch?v=aUhZ... #CancerResearch #AIinOncology

🚨 Just 2 days left to register!   Join us on 15 Oct, 14:00 CEST for our webinar on AI in early cancer detection with @phireproject.bsky.social , @pancaid.bsky.social, and #PANCAIM  🔗 Register now: https://tinyurl.com/PPPWebinarOnAI   #AIinOncology #CancerResearch

🧠 How is AI transforming early cancer detection?  Join @phireproject.bsky.social, @pancaid.bsky.social, and #PANCAIM on 15 October, 14:00 CEST for a 60-min webinar.  🔗 Register: https://tinyurl.com/PPPWebinarOnAI    #AI #CancerDiagnosis #Webinar

🚨 New PANCAID Masterclass! How is #AI transforming pancreatic cancer research? Dr Núria Malats & Sergio Sabroso (CNIO) explain its role in early detection and #precisiononcology. ▶️ https://youtu.be/H-_Xv3H7fZI @nuriamalats.bsky.social @cniostopcancer.bsky.social  #CancerResearch #PancreaticCancer

🎙️Join us for the webinar “Approaches to Early Cancer Diagnosis & the Impact of #AIinOncology”  🗣️ Moderated by Federica Zanca, EIC Programme Manager  👥 Panelists:  @phireproject.bsky.social – Massimo Alfano  @pancaid.bsky.social  – @nuriamalats.bsky.social  #PANCAIM – John Hermans  #Webinar

Join our webinar “Approaches to Early Cancer Diagnosis and the Impact of Artificial Intelligence in Oncology”! @phireproject.bsky.social, #PANCAIM & @pancaid.bsky.social are proud to discuss how AI is transforming #oncology. 🔗 Register: events.teams.microsoft.com/event/1fba7a... #CancerResearch

@pancaid.bsky.social is testing the best #liquidbiopsy for the early detection of #pancreaticcancer! Proud to be part of it @ki.se @hpb-karolinska.bsky.social

🚀 Partner spotlight: @zavamed.bsky.social Leading telehealth platform ensure the readiness for a digital end-to-end patient pathway. Contributing to: 📍 WP1 – Patient cohort definition & biomaterial collection 📍 WP6 – Dissemination & communication #HorizonEurope #DigitalHealth #Telemedicine

It’s #RNAday! RNA, especially #microRNA, plays an important role in our research: Part of WP2 is profiling multi-omics data, where we analyse genomic, epigenomic, transcriptomic, microRNA and metabolomic data from #PDAC patients. #pancreaticcancer ➡️ https://pancaid-project.eu/research/work-packages/

Plus we are analysing samples from #pancreaticcancer patients for #extracellularvesicles #EV @danielhagey

🔬 This week’s #PANCAID partner spotlight: @regionstockholm.bsky.social (RS)! RS contributes to WP1 via Karolinska University Hospital, working with Prof. Löhr's group on clinical recruitment & biobanking. @hpb-karolinska.bsky.social @maloehr.bsky.social @ki.se #HorizonEurope #CancerResearch

🔦 #PANCAIDPartnerSpotlight: The University of Cambridge (via @cruk-ci.bsky.social) powers WP2 & WP3, and contributes expertise in circulating tumour DNA (ctDNA) analysis and multi-omic data integration. #CancerResearch #PancreaticCancer #EarlyDetection

🔦 #PANCAIDPartnerSpotlight: FIBIRYCIS brings expertise in #LiquidBiopsy, cancer genetics & PDAC biomarkers to WP1 – supporting sample & data collection across pancreatic lesions. Part of the Ramón y Cajal Health Research Institute. #CancerResearch #PancreaticCancer #EarlyDetection

🔦 This week’s #PANCAIDPartnerSpotlight: KSM Innovation / MACCABI KSM's strengths are: 📊 Access to 30+yrs of digital health data from 2.7M members 🧬 900K biobank samples In PANCAID, they contribute to WP1 by providing blood samples #HealthData #CancerDetection #Biobank

🔦 PANCAID Partner Spotlight: @collectiveminds.bsky.social Co-Leading WP3: Data management & AI 🔍 CMR powers our secure, multimodal data infrastructure: 📊 Repository design 🔐 Privacy & governance #PANCAID #DataManagement #CancerResearch

🔦 PANCAID Partner Spotlight: @hebrewuniversity.bsky.social The Dor & Kaplan labs lead epigenetic and ML innovation for PANCAID. 🔬 Dor Group: cfDNA tissue-of-origin via DNA methylation 🧠 Kaplan Group: Multi-omics modeling with advanced machine learning #CancerDetection #PancreaticCancer

PANCAID is proud to share that coordinator Klaus Pantel will speak at the G7 Cancer conference in Paris on June 26. 🕚 11:50 AM 💬 Talk: Early diagnosis and detection of minimally residual disease in #pancreaticcancer using #liquidbiopsy More info: g7cancer-events.com #G7Cancer

🔦 PANCAID Partner Spotlight: @uu.se The labs of @masoodkamali.bsky.social & @globischlab.bsky.social bring cutting-edge EV, proteomics & metabolomics expertise to PANCAID. 🟣 Working together on biomarker discovery in WP2. @scilifelab.se #Metabolomics #CancerResearch

🔦 PANCAID Partner Spotlight: University Hospital Heidelberg (UKHD) UKHD’s European Pancreas Center (EPZ) provides key biosamples & serum proteomics for PANCAID. With 10k+ samples in PancoBank, their biobank is critical to early detection research. #PancreaticCancer #Proteomics

📢 New review from PANCAID's WP4: Cost-effectiveness of #earlydetection in #pancreaticcancer 🧾💶 ➡️ Some strategies work well, but inconsistencies in methods limit broader conclusions. Read the full paper: link.springer.com/article/10.1... @drchrisbrett.bsky.social #HealthEconomics

🧠 Midpoint check-in! Today, PANCAID held its 6th Steering Committee meeting as we hit the halfway mark of our #HorizonEU project. WP leads aligned strategy & next steps for advancing early #PancreaticCancer detection. We’re buzzing for what’s ahead! ⚡ #CancerResearch #LiquidBiopsy

🔦 PANCAID Partner Spotlight: CHU de Montpellier At LCCRH, CHUM pioneers CTC research to drive early cancer detection. They support WP2, WP3 & WP6: from biomarker discovery to data science and training young researchers. @cathiepana.bsky.social #LiquidBiopsy #CancerResearch #PancreaticCancer

Today is #WorldDigestiveHealthDay 🟣 PANCAID aims to tackle one of the biggest challenges in digestive health: the late detection of #PancreaticCancer. We're working on a minimally invasive blood test to catch it early, when it’s still treatable. #EarlyDetection #CancerResearch

🧬 New research: Fecal #metabolomics reveals key differences between autoimmune & chronic pancreatitis, unlocking potential for novel diagnostics! 📄 Read the study: onlinelibrary.wiley.com/doi/full/10.... @maloehr.bsky.social @globischlab.bsky.social #PancreaticCancer #Biomarkers #liquidbiopsy

🔦 PANCAID Partner Spotlight: #UKSH UKSH co-leads WP1 in PANCAID: Defining patient cohorts & guiding biomaterial collection. With 650+ cancer & 100+ control samples from TRIBanK, they power biomarker discovery for early #pancreaticcancer detection. @sebens-iet-kiel.bsky.social

PANCAID Coordinator Prof. Klaus Pantel joins a high-level seminar on #PrecisionDiagnostics & NGS in cancer care, hosted by MEP Vlad Voiculescu, organised by #Instand-NGS4P The message: We need to accelerate access to innovative diagnostics like #LiquidBiopsy for every patient in 🇪🇺.

🔦 PANCAID Partner Spotlight: @concentris.bsky.social As project office & WP6 lead, concentris keeps PANCAID running smoothly, from coordination to communication, training & impact. Their expert team supports EU research from start to finish. #ResearchManagement #SciComm #HorizonEurope

🔦 PANCAID Partner Spotlight: @pce-europe.bsky.social PCE co-leads PANCAID's communication & dissemination efforts (WP6), ensuring research reaches patients, policymakers & the public. Their work unites 80+ European experts to improve survival & awareness. #PancreaticCancer #Advocacy

Klaus Pantel presented the Young Investigator Award at #ISMRC2025, alongside Catherine Alix-Panabières and Paul Hofman. It's especially wonderful to see PANCAID members received two silver and one gold award! Heartfelt congratulations for your work (outside PANCAID)

🧠 “Transforming cancer patient management: the intersection of #AI and #LiquidBiopsy”, Núria Malats explores the perspectives of liquid biopsy at #ISMRC2025. @nuriamalats.bsky.social #CancerResearch

🩸🔬 Kicking off the final day at #ISMRC2025: PANCAID’s WP3 lead Núria Malats ( @nuriamalats.bsky.social from CNIO) moderates today’s session on the latest developments in #LiquidBiopsy #PANCAID #CancerResearch #EarlyDetection

What’s next for #LiquidBiopsy? 💡 Nitzan Rosenfeld just outlines the future: smaller, cheaper, faster. #ISMRC2025 #EarlyDetection

Just hearing from Yuval Dor 🇮🇱 on the power of #epigenetics in #liquidbiopsy at #ISMRC2025 🧬

Day 2 at #ISMRC2025 begins with a spotlight on Early Detection of Cancer We're proud to see two of our collaborators take leading roles today: 🗣 Ellen Heitzer and Nitzan Rosenfeld co-moderate this morning’s session #EarlyDetection #CancerDetection

🧪 Daniel Hagey explores tumor-derived DNA dynamics in pancreatic cancer here at #ISMRC2025 @maloehr.bsky.social #LiquidBiopsy #PancreaticCancer #EarlyDetection

🩸🔍 We’re now at the afternoon session “minimal residual cancer detection and characterization”, which is co-moderated by PANCAID coordinator Klaus Pantel #MRD #cancerdetection

Next up: Keerthi Kurma on decoding immune signals from blood via #liquidbiopsy 🩸 #ISMRC2025 #ImmunoOncology

Now at the ARC Foundation session on #CancerImmunology + #AI at #ISMRC2025: 🧬 Catherine Alix-Panabières ( @cathiepana.bsky.social ) shows how CTCs are advancing immuno-oncology 🔍 🎯 PANCAID’s focus on multi-analyte LBx fits right in. #ISMRC2025 #liquidbiopsy

🧬 First up: Opening lecture by PANCAID coordinator Klaus Pantel: Tracing tumor evolution by liquid biopsy #EarlyDetection #CancerResearch

Good morning from #ISMRC2025 👋 Kicking off Day 1 with opening remarks from Paul Hofman, Klaus Pantel & Catherine Alix-Panabières (@CathiePana.bsky.social) — setting the tone for a liquid biopsy–driven conference! #PANCAID